158 filings
Page 5 of 8
8-K
2cniw3xmn7
9 Sep 21
Entry into a Material Definitive Agreement
4:02pm
8-K
lykitnvu97nc36s gr
2 Sep 21
Keros Therapeutics to Participate in Two Upcoming Healthcare Conferences
8:02am
8-K
saxf pplpet2q05oiekb
5 Aug 21
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
4:03pm
8-K
janux52ga6juguh cu2
2 Aug 21
Keros Therapeutics Appoints Simon Cooper, M.B.B.S. as Chief Medical Officer
9:02am
8-K
vpy0iu
22 Jun 21
June 2021 Corporate Presentation
4:08pm
8-K
kc614ly q1gn115o
11 Jun 21
Other Events
8:03am
8-K
mbdrbmlrbg3fjrsxr8
1 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
hnnt2tw 8wy1fm1p
27 May 21
Keros Therapeutics to Present at the Jefferies Virtual Healthcare Conference
8:06am
8-K
tyvmu4 75q
25 May 21
Keros Therapeutics Announces Issuance of U.S. Patent for Use of Therapeutic Proteins in Treatment of Musculoskeletal Disorders
8:04am
8-K
yitd7s5oym leer8gqb
14 May 21
Other Events
8:01am
8-K
69fyvkr29ccgvi3vh
12 May 21
Keros Therapeutics to Present at the Virtual 26th Annual Congress of the European Hematology Association
4:03pm
8-K
gt7e1e 7iy01e3f26h
6 May 21
May 2021 Corporate Presentation
4:20pm
8-K
zpls9x 5tl2h
6 May 21
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
4:03pm
S-3ASR
l9vp2pb
3 May 21
Automatic shelf registration
4:33pm
DEFA14A
yo86cl
19 Apr 21
Additional proxy soliciting materials
4:17pm
DEF 14A
7ejew4 fszgegi
19 Apr 21
Definitive proxy
4:15pm
8-K
7l0y2
25 Mar 21
March 2021 Corporate Presentation
8:31am
10-K
qhsrto 53rll
25 Mar 21
Annual report
8:23am